OpenSAFELY Vaccine Coverage Report

AstraZeneca / Priority Group 5

Data from combined, up to 2021-03-07.

Vaccinated at 2021-03-07 (%) Vaccinated at 2021-03-07 (n) Population Vaccinated at 2021-02-28 (%) Vaccinated in past week (%)
Overall - 56.6% 1,396,822 2,469,026 53.3% 3.3%
Sex Female 56.6% 712,593 1,259,475 53.3% 3.3%
Male 56.6% 684,229 1,209,551 53.3% 3.3%
Ethnicity White - British 59.5% 859,208 1,445,248 56.3% 3.2%
White - Irish 54.2% 8,435 15,568 51.6% 2.6%
White - Any other White background 41.1% 32,494 79,128 38.5% 2.5%
Mixed - White and Black Caribbean 37.6% 1,190 3,164 33.8% 3.8%
Mixed - White and Black African 37.9% 973 2,569 34.6% 3.3%
Mixed - White and Asian 50.3% 1,281 2,548 47.5% 2.7%
Mixed - Any other mixed background 43.7% 2,149 4,921 40.5% 3.1%
Asian or Asian British - Indian 51.2% 25,725 50,218 49.2% 2.0%
Asian or Asian British - Pakistani 42.3% 10,570 24,983 38.9% 3.4%
Asian or Asian British - Bangladeshi 48.5% 2,996 6,174 44.2% 4.3%
Asian or Asian British - Any other Asian background 46.4% 10,388 22,407 43.8% 2.6%
Black or Black British - Caribbean 34.3% 5,117 14,924 30.8% 3.5%
Black or Black British - African 34.8% 5,299 15,211 31.1% 3.8%
Black or Black British - Any other Black background 38.2% 1,386 3,633 34.3% 3.9%
Other ethnic groups - Chinese 45.0% 4,221 9,380 41.6% 3.4%
Other ethnic groups - Any other ethnic group 40.1% 5,306 13,216 37.3% 2.9%
Patients with any other ethnicity code 56.3% 184,002 326,662 52.8% 3.6%
Ethnicity not stated 54.4% 8,225 15,120 50.9% 3.5%
Ethnicity not recorded 55.0% 227,759 413,847 51.3% 3.8%
Ethnicity (broad categories) White 58.5% 900,151 1,539,958 55.3% 3.2%
Mixed 42.4% 5,600 13,209 39.4% 3.0%
South Asian 47.9% 49,700 103,796 45.2% 2.6%
Black 35.0% 11,816 33,782 31.3% 3.7%
Other 42.2% 9,534 22,610 39.0% 3.1%
Unknown 55.6% 419,993 755,650 51.9% 3.7%
Index of Multiple Deprivation 1 (most deprived) 53.8% 414,225 769,692 50.5% 3.4%
2 53.6% 190,463 355,047 49.7% 4.0%
3 56.8% 241,521 425,523 53.2% 3.5%
4 59.1% 264,320 446,950 56.1% 3.1%
5 (least deprived) 61.0% 274,491 450,282 58.4% 2.6%
Unknown 54.7% 11,781 21,518 49.7% 5.0%
Clinical Risk Groups Patients in Any Clinical Risk Group 57.1% 515,473 902,923 53.8% 3.3%
Patients with Immunosuppression 58.1% 21,819 37,541 55.1% 3.0%
Patients with CKD 57.7% 66,913 115,997 54.5% 3.2%
Patients who have Chronic Respiratory Disease 57.0% 54,950 96,425 53.6% 3.4%
Patients with Diabetes 56.4% 182,798 324,366 53.1% 3.3%
Patients with Chronic Liver disease 56.1% 41,153 73,311 52.9% 3.2%
Patients with CNS Disease (including Stroke/TIA) 57.8% 77,903 134,673 54.1% 3.7%
Patients with Chronic heart disease 57.8% 216,055 374,017 54.5% 3.3%
Patients with Asplenia or Dysfunction of the Spleen 59.7% 8,435 14,140 56.5% 3.1%
Patients with Wider Learning Disability 51.9% 3,010 5,796 44.3% 7.6%
Patients with Severe Mental Health 50.1% 11,865 23,688 45.4% 4.7%
Other Groups Patients with Morbid Obesity 56.4% 43,897 77,875 52.7% 3.7%
Patients who are pregnant 58.3% 147 252 55.6% 2.8%